BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeznach-Steinhagen A, Ostrowska J, Czerwonogrodzka-Senczyna A, Boniecka I, Shahnazaryan U, Kuryłowicz A. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina (Kaunas) 2019;55:E166. [PMID: 31137547 DOI: 10.3390/medicina55050166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mascaró CM, Bouzas C, Montemayor S, Casares M, Llompart I, Ugarriza L, Borràs PA, Martínez JA, Tur JA. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome. Nutrients 2022;14:1813. [PMID: 35565780 DOI: 10.3390/nu14091813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mascaró CM, Bouzas C, Montemayor S, Casares M, Gómez C, Ugarriza L, Borràs P, Martínez JA, Tur JA. Association between Stages of Hepatic Steatosis and Physical Activity Performance in Adults with Metabolic Syndrome: A Cross-Sectional Analysis in FLIPAN Study. Nutrients 2022;14:1790. [DOI: 10.3390/nu14091790] [Reference Citation Analysis]
3 Mascaró CM, Bouzas C, Montemayor S, Casares M, Gómez C, Ugarriza L, Borràs PA, Martínez JA, Tur JA. Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study. Nutrients 2022;14:1063. [PMID: 35268038 DOI: 10.3390/nu14051063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bestavashvili A, Glazachev O, Bestavashvili A, Suvorov A, Zhang Y, Zhang X, Rozhkov A, Kuznetsova N, Pavlov C, Glushenkov D, Kopylov P. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines 2022;10:566. [PMID: 35327372 DOI: 10.3390/biomedicines10030566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mascaró CM, Bouzas C, Tur JA. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. Nutrients 2021;14:49. [PMID: 35010923 DOI: 10.3390/nu14010049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
6 Głuszyńska P, Lemancewicz D, Dzięcioł JB, Razak Hady H. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. J Clin Med 2021;10:5721. [PMID: 34945016 DOI: 10.3390/jcm10245721] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Al-Baiaty FDR, Ismail A, Abdul Latiff Z, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Front Pediatr 2021;9:667247. [PMID: 34307250 DOI: 10.3389/fped.2021.667247] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Stevanović-Silva J, Beleza J, Coxito P, Costa RC, Ascensão A, Magalhães J. Fit mothers for a healthy future: Breaking the intergenerational cycle of non-alcoholic fatty liver disease with maternal exercise. Eur J Clin Invest 2021;:e13596. [PMID: 34120338 DOI: 10.1111/eci.13596] [Reference Citation Analysis]
9 Errafii K, Al-Akl NS, Khalifa O, Arredouani A. Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4. J Transl Med 2021;19:235. [PMID: 34078383 DOI: 10.1186/s12967-021-02885-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, Dehnad A. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Phytother Res 2021;35:3145-56. [PMID: 33880813 DOI: 10.1002/ptr.6972] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants (Basel) 2021;10:364. [PMID: 33670839 DOI: 10.3390/antiox10030364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
12 Crawford MS, Mohr AE, Sweazea KL. Novel Organic Mineral Complex Prevents High-Fat Diet-Induced Changes in the Gut and Liver of Male Sprague-Dawley Rats. J Nutr Metab 2020;2020:8846401. [PMID: 33414960 DOI: 10.1155/2020/8846401] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Han H, Li X, Guo Y, Zheng M, Xue T, Wang L. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling. Food Funct 2021;12:2171-88. [DOI: 10.1039/d0fo02623a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Stachowska E, Portincasa P, Jamioł-Milc D, Maciejewska-Markiewicz D, Skonieczna-Żydecka K. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2020;12:E3460. [PMID: 33187278 DOI: 10.3390/nu12113460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhang Y, Liu Z, Choudhury T, Cornelis MC, Liu W. Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study. Eur J Nutr 2021;60:1761-7. [PMID: 32856188 DOI: 10.1007/s00394-020-02369-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Durazzo M, Marzari L, Bonetto S, Ferro A, Ghigo MC, Belci P, Collo A, Fagoonee S. Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores. Minerva Gastroenterol Dietol 2020;66:301-6. [PMID: 32700500 DOI: 10.23736/S1121-421X.20.02753-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Amaral JATD, Salatini R, Arab C, Abreu LC, Valenti VE, Monteiro CBM, Tannuri U, Tannuri ACA. Non-Alcoholic Cirrhosis and Heart Rate Variability: A Systematic Mini-Review. Medicina (Kaunas) 2020;56:E116. [PMID: 32151106 DOI: 10.3390/medicina56030116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Drescher HK, Weiskirchen S, Weiskirchen R. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells 2019;8:E845. [PMID: 31394730 DOI: 10.3390/cells8080845] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 15.0] [Reference Citation Analysis]